MCCP
BMY icon

Mission Creek Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Mission Creek Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,094
Closed -$212K – 224
2024
Q2 		$212K Sell
5,094
-10,909
-68% -$488K 0.05% 200
2024
Q1 		$868K Sell
16,003
-10,558
-40% -$538K 0.23% 118
2023
Q4 		$1.36M Buy
26,561
+1,270
+5% +$66.7K 0.35% 84
2023
Q3 		$1.47M Buy
25,291
+1,130
+5% +$69.2K 0.49% 63
2023
Q2 		$1.55M Buy
24,161
+3,326
+16% +$223K 0.5% 63
2023
Q1 		$1.44M Buy
20,835
+4,359
+26% +$307K 0.49% 74
2022
Q4 		$1.19M Buy
16,476
+110
+0.7% +$8.29K 0.42% 83
2022
Q3 		$1.16M Buy
16,366
+938
+6% +$68K 0.44% 81
2022
Q2 		$1.19M Buy
15,428
+251
+2% +$19.1K 0.4% 90
2022
Q1 		$1.11M Buy
15,177
+833
+6% +$55.9K 0.3% 108
2021
Q4 		$894K Buy
14,344
+474
+3% +$27.8K 0.18% 140
2021
Q3 		$821K Buy
13,870
+1,103
+9% +$72.6K 0.15% 140
2021
Q2 		$853K Buy
12,767
+3,941
+45% +$257K 0.14% 125
2021
Q1 		$557K Buy
8,826
+622
+8% +$38.7K 0.08% 149
2020
Q4 		$509K Buy
8,204
+2,878
+54% +$177K 0.16% 143
2020
Q3 		$321K Buy
5,326
+660
+14% +$39.7K 0.13% 169
2020
Q2 		$274K Sell
4,666
-344
-7% -$20.6K 0.14% 143
2020
Q1 		$279K Sell
5,010
-46
-0.9% -$2.81K 0.15% 134
2019
Q4 		$325K Buy
+5,056
New +$290K 0.15% 148

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mission Creek Capital Partners's BMY Position: Q3 2024 in Review

Mission Creek Capital Partners sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 5,094 shares — an estimated $212K sold.

Mission Creek Capital Partners first reported a position in BMY in Q4 2019 and held it in 19 quarters. The position peaked at $1.55M in Q2 2023. 2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Mission Creek Capital Partners reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
  • Mission Creek Capital Partners sold 5,094 Bristol-Myers Squibb shares in Q3 2024, an estimated $212K.
  • Mission Creek Capital Partners first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 19 quarters.
  • Mission Creek Capital Partners's Bristol-Myers Squibb position peaked at $1.55M in Q2 2023.
  • 2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Mission Creek Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.